Summary:
ICON Development Solutions is conducting a research study for healthy adults ages 18-65, who are Type II Diabetics. This study is being done to test the safety and tolerability of an investigative drug for better glycemic control of Type 2 Diabetes. This study drug will be administered orally.
Vital signs, ECGs, CGM/Continuous Glucose Monitor testing and physical examinations will be performed as well as blood and urine samples will be obtained during this study.
Participants will complete:
- 1 screening visit
- 2 periods of 3 overnights each
- 4 outpatient visits
Qualified Participants May Receive:
Compensation up to $3,050 for time and travel.